Literature DB >> 11173496

An efficient method for solving RNA structures: MAD phasing by replacing magnesium with zinc.

E Ennifar 1, P Walter , P Dumas .   

Abstract

The structure of a 46-nucleotide RNA complex has been successfully solved using multi-wavelength anomalous dispersion (MAD) at the zinc K edge. Taking advantage of the eight magnesium-binding sites, it has been shown that for five of them magnesium could be replaced by zinc. This resulted in an excellent 2.0 A MAD electron-density map. Zinc, in common with some other transition metals, is able to replace magnesium in RNA structures, but zinc has the advantage of its K edge being ideally located at 1.284 A. As most RNA molecules contain magnesium-binding sites, it is suggested that this method could be a valuable alternative to the use of bromo derivatives of bases, which is limited to chemically synthesizable and thus rather short RNA sequences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11173496     DOI: 10.1107/s0907444900017558

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  4 in total

1.  Encapsulating streptomycin within a small 40-mer RNA.

Authors:  Valentina Tereshko; Eugene Skripkin; Dinshaw J Patel
Journal:  Chem Biol       Date:  2003-02

2.  A crystallographic study of the binding of 13 metal ions to two related RNA duplexes.

Authors:  Eric Ennifar; Philippe Walter; Philippe Dumas
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

3.  Influence of C-5 halogenation of uridines on hairpin versus duplex RNA folding.

Authors:  Eric Ennifar; Serena Bernacchi; Philippe Wolff; Philippe Dumas
Journal:  RNA       Date:  2007-07-13       Impact factor: 4.942

4.  2'-Methylseleno-modified oligoribonucleotides for X-ray crystallography synthesized by the ACE RNA solid-phase approach.

Authors:  Barbara Puffer; Holger Moroder; Michaela Aigner; Ronald Micura
Journal:  Nucleic Acids Res       Date:  2007-12-20       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.